abstract |
The present invention is for the treatment, prevention or management of diseases and conditions including hyperproliferative disorders such as cancer in humans and other mammals, regorafenib and acetylsalicylic acid, or a hydrate, solvate, and metabolite thereof ( metabolite) or a pharmaceutically acceptable salt or polymorph thereof. |